Vulnerability · CVE-2026-30944
StudioCMS is a server-side-rendered, Astro native, headless content management system.
Published Mar 10, 2026 · catalog updated Jun 17, 2026 · StudioCMS is a server-side-rendered,
Check if you run it
No confirmed exploitation is on record for CVE-2026-30944. EPSS is 0.56%. Act only if a listed version of StudioCMS is a server-side-rendered, is installed.
Gaps on this record
- The stored product name is a package slug. The name on this page is taken from the title (StudioCMS is a server-side-rendered,).
- No version range is stored. A customer cannot check an installed version against this record.
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
- Severity
- High8.8
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 0.56%
- Remediation
- Advisory link
- Affected products
- cpe studiocms/studiocms
StudioCMS is a server-side-rendered, Astro native, headless content management system. Prior to 0.4.0, the /studiocms_api/dashboard/api-tokens endpoint allows any authenticated user (at least Editor) to generate API tokens for any other user, including owner and admin accounts. The endpoint fails to validate whether the requesting user is authorized to create tokens on behalf of the target user ID, resulting in a full privilege escalation. This vulnerability is fixed in 0.4.0.
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- cpe studiocms/studiocmsversion unspecified
How to fix CVE-2026-30944
Recommended remediation
A patch or advisory reference is linked. Open the original publisher for availability by product version.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
No confirmed exploitation is on record for CVE-2026-30944. EPSS is 0.56%. Act only if a listed version of StudioCMS is a server-side-rendered, is installed.
Which versions are affected?
Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
CWE-639: Authorization Bypass Through User-Controlled Key; CWE-863: Incorrect Authorization. EPSS 0.56%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
Timeline
Detection, updates, and resolution for this record.
Mar 10, 2026 · NIST NVD
Detected
StudioCMS is a server-side-rendered, Astro native, headless content management system. Prior to 0.4.0, the /studiocms_api/dashboard/api-tokens endpoint allows any authenticated user (at least Editor) to generate API tokens for any other user, including owner and admin accounts. The endpoint fails to validate whether the requesting user is authorized to create tokens on behalf of the target user ID
Jun 17, 2026 · NIST NVD
Updated
StudioCMS is a server-side-rendered, Astro native, headless content management system. Prior to 0.4.0, the /studiocms_api/dashboard/api-tokens endpoint allows any authenticated user (at least Editor) to generate API tokens for any other user, including owner and admin accounts. The endpoint fails to validate whether the requesting user is authorized to create tokens on behalf of the target user ID
Sources
- CVE.orgVulnerability recordCVE-2026-30944
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2026-30944
30-day exploitation probability 0.6%
first.org - NIST NVDVulnerability recordCVE-2026-30944
StudioCMS is a server-side-rendered, Astro native, headless content management system. Prior to 0.4.0, the /studiocms_api/dashboard/api-tokens endpoint allows any authenticated user (at least Editor) to generate API tokens for any other user, including owner and admin accounts. T
nvd.nist.gov
References
Freshness
Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.